Saturday 17 October 2026
Export ECOR’s income statement to Excel — free account
electroCore, Inc.
ECOR Healthcare Medical Devices
electroCore, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 27.2% from fiscal 2024. In the quarter to June 2026, revenue grew 28.0%, EPS grew 25.0% and free cash flow fell 443.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
7.85
0.50
−5.99%
Follow ECOR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 6 | 4 | 4 | 6 | 4 | 3 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(13.54) | (6.79) | (14.58) | (8.87) | (1.23) | (1.86) | (4.27) | 12.93 | — | — |
P/S ratio |
1.19 | 4.82 | 2.05 | 2.20 | 6.33 | 17.41 | 19.55 | 184.57 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(36.67) | (29.29) | (38.07) | (19.40) | (1.47) | (9.20) | (10.72) | 8.67 | (6.24) | (729.23) |
Beneish M-Score |
(4.52) | (2.44) | (3.21) | (3.70) | (2.51) | (3.93) | 14.39 | 0.67 | (1.34) | — |
P/Operating CF |
(24.73) | (96.65) | (10.54) | (4.70) | (7.93) | (17.00) | (5.13) | (15.05) | 0.00 | 0.00 |
P/B ratio |
0.00 | 16.08 | 4.42 | 1.10 | 0.94 | 2.57 | 1.88 | 2.77 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 16.08 | 4.42 | 1.10 | 0.94 | 2.57 | 1.88 | 2.77 | 0.00 | 0.00 |
EV/Sales |
1.04 | 4.36 | 1.43 | 0.19 | 0.11 | 11.54 | 10.33 | 119.69 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(4.05) | (15.79) | (1.57) | (0.10) | (0.04) | (2.01) | (0.55) | (2.52) | (0.11) | (0.11) |
EV/FCF |
(4.02) | (15.34) | (1.55) | (0.10) | (0.04) | (2.01) | (0.55) | (2.51) | (0.11) | (0.11) |
Quick Ratio |
1.11 | 1.48 | 1.39 | 2.61 | 6.40 | 3.89 | 2.69 | 9.73 | 6.09 | 0.11 |
Current Ratio |
1.38 | 1.78 | 1.76 | 3.01 | 6.84 | 4.26 | 2.90 | 10.28 | 6.38 | 0.12 |
Net Debt/EBITDA |
0.40 | 1.07 | 0.58 | 0.78 | 1.74 | 0.89 | 0.49 | 1.25 | 1.79 | (0.26) |
Debt/Assets |
35.39% | 0.00% | 0.00% | 2.52% | 1.63% | 3.48% | 4.00% | 0.00% | 5.71% | 666.66% |
Debt/Equity |
(3.87) | 0.00 | 0.00 | 0.04 | 0.02 | 0.05 | 0.06 | 0.00 | 0.07 | (0.55) |
Asset Turnover |
1.64 | 1.38 | 0.78 | 0.25 | 0.15 | 0.10 | 0.04 | 0.02 | 0.04 | 0.01 |
Operating CF/Net income |
0.59 | 0.58 | 0.78 | 0.75 | 0.79 | 0.85 | 1.00 | 1.36 | 0.00 | 0.84 |
Capex/Depreciation |
(0.10) | 0.00 | (0.21) | 0.00 | 0.00 | 0.00 | 0.25 | 0.65 | (0.02) | 0.00 |
Interest Coverage |
(22.29) | (31.26) | — | (79.70) | (1,873.18) | (266.97) | (47.48) | (54.21) | (4.07) | (64.04) |
| (478.70%) | (158.63%) | (153.57%) | (82.49%) | (57.11%) | (96.87%) | (99.14%) | 298.10% | 0.00% | 20.83% | |
| (71.37%) | (65.00%) | (92.19%) | (65.58%) | (46.32%) | (70.20%) | (82.87%) | (61.56%) | 0.00% | (78.97%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (471.20%) | (731.55%) | (1,275.76%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(297.15%) | (162.69%) | (295.44%) | (156.31%) | (53.47%) | (121.08%) | (254.59%) | (52.57%) | 0.00% | 439.47% |
Average Days of Receivables |
11.70 | 19.81 | 16.33 | 17.04 | 29.33 | 28.24 | 75.75 | 98.36 | 46.42 | 35.48 |
Research and Development Expense of Revenue |
8.54% | 9.37% | 33.19% | 64.25% | 46.52% | 120.18% | 414.27% | 1,255.41% | 964.99% | 3,137.07% |
Selling, General and Administrative Expense of Revenue |
119.27% | 123.89% | 169.52% | 283.17% | 395.76% | 624.78% | 1,481.92% | 4,280.12% | 2,231.26% | 2,821.45% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
6.03% | 7.43% | 10.59% | 31.22% | 60.41% | 97.91% | 162.98% | 765.31% | 56.97% | 56.12% |
Graham Net Nets |
(0.12) | 0.03 | 0.17 | 0.72 | 0.91 | 0.28 | 0.34 | 0.36 | 0.00 | 0.00 |
Graham Number |
2.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(36.75%) | (9.99%) | (59.63%) | (120.76%) | (51.40%) | (41.01%) | (96.18%) | (18.85%) | (9.22%) | (9.22%) |
Free Cash Flow Yield |
(21.67%) | (5.90%) | (45.17%) | (88.58%) | (39.68%) | (33.06%) | (96.58%) | (25.86%) | 0.00% | 0.00% |
Revenue per Share |
3.78 | 3.37 | 2.91 | 1.82 | 1.38 | 1.34 | 1.22 | 0.51 | 0.00 | 0.03 |
Operating CF per Share |
(0.97) | (0.93) | (2.66) | (3.52) | (3.45) | (7.71) | (23.00) | (24.14) | 0.00 | (1.32) |
Capex per Share |
(0.01) | 0.00 | (0.04) | 0.00 | 0.00 | 0.00 | (0.04) | (0.14) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.97) | (0.93) | (2.70) | (3.52) | (3.45) | (7.71) | (23.03) | (24.28) | 0.00 | (1.32) |
Cash per Share |
1.37 | 1.63 | 1.92 | 3.80 | 8.79 | 8.70 | 12.28 | 35.13 | 0.00 | 0.04 |
Shareholders Equity per Share |
(0.20) | 1.01 | 1.35 | 3.61 | 9.29 | 9.09 | 12.71 | 33.91 | 0.00 | (0.75) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.20) | 1.01 | 1.35 | 3.61 | 9.29 | 9.09 | 12.71 | 33.91 | 0.00 | (0.75) |
Free Cash Flow |
(8.25) | (6.95) | (14.87) | (16.64) | (13.63) | (20.05) | (45.14) | (47.39) | (25.48) | (13.23) |
Working Capital |
4.32 | 7.15 | 6.17 | 14.13 | 32.06 | 19.17 | 17.39 | 65.63 | 32.91 | (3.63) |
Capital Expenditures |
(0.07) | — | (0.21) | — | — | — | (0.07) | (0.28) | (0.15) | — |
Net Current Asset Value |
(4.71) | 3.37 | 5.63 | 13.50 | 31.36 | 17.19 | 15.97 | 65.38 | 32.61 | (7.65) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.03 | 0.28 | 0.19 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.66 | 4.81 | 4.72 | 10.96 | 3.56 | 1.76 | (0.81) | (1.13) | 36.25 | 12.20 |
Cash ROIC |
(49.99%) | (35.16%) | (82.53%) | (46.66%) | (18.92%) | (42.33%) | (89.60%) | (35.17%) | (35.28%) | 445.00% |
Accounts Receivable Turnover |
26.76 | 24.17 | 28.68 | 20.48 | 15.39 | 9.12 | 6.26 | 5.36 | 12.69 | 3.97 |
Accounts Payable Turnover |
1.87 | 1.90 | 1.31 | 1.05 | 0.92 | 0.48 | 0.29 | 0.33 | 0.25 | 0.06 |
Inventory Turnover |
2.57 | 1.97 | 1.35 | 0.97 | 1.24 | 1.97 | 0.81 | 0.51 | 2.76 | 0.66 |
Average Days of Payables |
233.24 | 176.18 | 281.56 | 480.87 | 247.20 | 436.68 | 1,643.29 | 1,702.26 | 591.60 | 9,726.94 |
Days of Inventory on Hand |
140.27 | 161.62 | 281.17 | 447.67 | 358.68 | 184.11 | 281.08 | 1,229.53 | 230.76 | 143.11 |
Average Receivables |
1.20 | 1.04 | 0.56 | 0.42 | 0.35 | 0.38 | 0.38 | 0.19 | 0.06 | 0.06 |
Average Payables |
2.27 | 2.00 | 2.15 | 1.53 | 1.51 | 3.64 | 3.95 | 1.77 | 2.07 | 2.07 |
Average Inventory |
1.65 | 1.92 | 2.07 | 1.67 | 1.12 | 0.88 | 1.42 | 1.14 | 0.19 | 0.19 |
Average Assets |
19.57 | 18.29 | 20.43 | 33.79 | 37.18 | 33.49 | 54.48 | 56.37 | 19.93 | 19.93 |
Average Common Equity |
2.92 | 7.49 | 12.26 | 26.87 | 30.15 | 24.27 | 45.54 | (11.64) | (75.26) | (75.56) |
Columns are period end dates